Antibiotic-resistant bacterial pathogens (ARBPs) are a global problem. ARBPs are becoming increasingly prevalent and cause severe morbidity and mortality in industrial and developing countries alike. It is foreseeable that current, antibiotic-based regimes to treat bacterial infections will become inapplicable in the coming decades. It is inevitable to act now and [...]
